• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Hum Immunol . Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China

tetano

Editor, Senior Moderator
Hum Immunol


. 2020 Sep 16;S0198-8859(20)30390-6.
doi: 10.1016/j.humimm.2020.08.006. Online ahead of print.
Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China


Xing Chen[SUP] 1 [/SUP], Jide Huang[SUP] 1 [/SUP], Ying Huang[SUP] 1 [/SUP], Jiabin Chen[SUP] 1 [/SUP], Yingyi Huang[SUP] 1 [/SUP], Xiaowen Jiang[SUP] 1 [/SUP], Yaling Shi[SUP] 2 [/SUP]



Affiliations

Abstract

To discover immune factors that can predict the progression of COVID-19, we evaluated circulating immune cells and plasma cytokines in COVID-19 patients. We found that T cells, including CD4[SUP]+[/SUP] T cells and CD8[SUP]+[/SUP] T cells, were significantly decreased in severe COVID-19 symptoms but not in mild symptoms, in comparison with healthy people. T cells remained at a low level after recovery from severe COVID-19. CD4[SUP]+[/SUP]CD25[SUP]+[/SUP]CD127[SUP]low[/SUP] Treg-enriched cells were significantly increased in either mild or severe COVID-19 patients, regardless of recovery or not. Moreover, in either mild or severe COVID-19 patients, Treg-enriched cells up-regulated CD25 and down-regulated CD127. After recovery, CD25 was partially down-regulated but still higher than the normal level, while CD127 returned to the normal level in mild patients but not severe patients. B cells were decreased in mild patients and further decreased in severe patients, and remained low after recovery. NK cells were decreased only in severe COVID-19, with a tendency to return to the normal level after recovery. Plasma IL-6 and IL-10 were both elevated in severe patients but not in mild patients. After recovery, IL-6 remained higher than its normal level, while IL-10 returned to the normal level. Binary logistic regression analysis indicated that CD4[SUP]+[/SUP] T cells, B cells, IL-6, and IL-10 were significantly associated with COVID-19 severity. Therefore, these parameters are indicators of COVID-19 severity. Dynamic monitoring of these parameters would benefit therapy planning and prognosis evaluation.

Keywords: COVID-19; Cytokines; Immune cells; Inflammation; SARS-CoV-2.
 
Back
Top Bottom